| Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug … S Tadesse, M Yu, LB Mekonnen, F Lam, S Islam, K Tomusange, ... Journal of medicinal chemistry 60 (5), 1892-1915, 2017 | 71 | 2017 |
| Targeting CDK9: a promising therapeutic opportunity in prostate cancer MH Rahaman, M Kumarasiri, LB Mekonnen, M Yu, S Diab, H Albrecht, ... Endocrine-related cancer 23 (12), T211-T226, 2016 | 71 | 2016 |
| Targeting CDK9 for treatment of colorectal cancer MH Rahaman, F Lam, L Zhong, T Teo, J Adams, M Yu, RW Milne, ... Molecular oncology 13 (10), 2178-2193, 2019 | 46 | 2019 |
| Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia S Diab, AM Abdelaziz, P Li, T Teo, SKC Basnet, B Noll, MH Rahaman, ... European journal of medicinal chemistry 139, 762-772, 2017 | 31 | 2017 |
| CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia MH Rahaman, Y Yu, L Zhong, J Adams, F Lam, P Li, B Noll, R Milne, ... Investigational New Drugs 37, 625-635, 2019 | 30 | 2019 |
| CDK12: a potential therapeutic target in cancer F Emadi, T Teo, MH Rahaman, S Wang Drug Discovery Today 25 (12), 2257-2267, 2020 | 18 | 2020 |
| Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation M Yu, T Teo, Y Yang, M Li, Y Long, S Philip, B Noll, GK Heinemann, ... European Journal of Medicinal Chemistry 214, 113248, 2021 | 17 | 2021 |
| Isolation, identification, in vitro antibiotic resistance and plant extract sensitivity of fire blight causing Erwinia amylovora MA Islam, MJ Alam, SA Urmee, MH Rahaman, MH Razu, RM Mazumdar Journal of Plant Pathology & Microbiology 5 (3), 1, 2014 | 16 | 2014 |
| Isolation, Identification, In Vitro Antibiotic Resistance and Plant Extract Sensitivity of Fire Blight Causing Erwinia amylovora MA Islam, MJ Alam, SA Urmee, MH Rahaman, MH Razu, RM Mazumdar Journal of Plant Pathology & Microbiology 5 (3), 1, 2014 | 16 | 2014 |
| Efficient in vitro micropropagation of Gynura procumbens-an important rare medicinal plant, through shoot tip and nodal segment explants F Parvin, J Islam, N Jahan, M Rahman Journal of Research in Biology, Online, 2231-6299, 2014 | 8 | 2014 |
| Investigation of a novel cyclin-dependent-kinase (CDK) inhibitor Cdki-73 as an effective treatment option for MLL-AML KL Li, SC Bray, D Iarossi, J Adams, L Zhong, B Noll, MH Rahaman, ... Blood 126 (23), 1365, 2015 | 6 | 2015 |
| Morphological and cytological effects of two herbicides on tetraploid wheat (Triticum durum L.) M Razu, S Zaman, R Akhter, M Rahman, MH Rahaman, M Mazid, G Kabir J. Biosci 20, 143-151, 2014 | 5 | 2014 |
| Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition S Islam, MH Rahaman, M Yu, B Noll, JH Martin, S Wang, R Head Cancers 15 (4), 1044, 2023 | 1 | 2023 |
| CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer R Rahman, MH Rahaman, AR Hanson, N Choo, J Xie, SL Townley, ... British Journal of Cancer, 1-14, 2024 | | 2024 |
| AU2-94: A CDK4-specific inhibitor with the marked anti-tumor efficacy L Bantie, J Likisa, M Rahaman, T Teo, A Safaroghliazar, SKC Basnet, ... Cancer Research 84 (6_Supplement), 5701-5701, 2024 | | 2024 |
| Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition. Cancers 2023, 15, 1044 S Islam, MH Rahaman, M Yu, B Noll, JH Martin, S Wang, R Head | | 2023 |
| LS007, a potent and orally bioavailable CDK9 inhibitor, suppresses the growth of triple-negative and estrogen receptor-positive breast cancer MH Rahaman, Y Zhang, MS Islam, G Heinemann, AT Anshabo, ... Cancer Research 79 (13_Supplement), 4427-4427, 2019 | | 2019 |
| CDKI-15, a novel and highly selective CDK4/6 inhibitor: discovery, in vitro and in vivo anticancer efficacy S Tadesse, L Bantie, K Tomusange, S Islam, MH Rahaman, B Noll, F Lam, ... Cancer Research 77 (13_Supplement), 2353-2353, 2017 | | 2017 |
| GDC-0032 inhibits MCF7-neo/HER2 cells proliferation Menu F Emadi, T Teo, MH Rahaman, S Wang | | |
| DRIFTED CATALYTIC PROPERTIES OF β-LACTAMASES DUE TO UNCONSTRAINED USE OF ANTIBIOTICS R Zaman, P Karmaker, SMN Hasan, MH Rahman, A Haque | | |
Hugo AlbrechtSenior Lecturer, University of South AustraliaVerified email at unisa.edu.au
